Literature DB >> 15238250

Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins.

Jörg Schirmer1, Klaus Aktories.   

Abstract

Mono-O-glycosylation of eukaryotic target proteins is the molecular mechanism of bacterial protein toxins of the family of large clostridial cytotoxins. This toxin family encompasses several high molecular mass proteins (>250 kDa) of various Clostridia species that are implicated in severe human diseases. Toxin A and toxin B from Clostridium difficile are the causative agents of pseudomembranous colitis and antibiotic-associated diarrhea. Lethal toxin and hemorrhagic toxin from Clostridium sordellii as well as alpha-toxin from Clostridium novyi are involved in the gas gangrene syndrome. The common mode of action of large clostridial cytotoxins is elicited by specific glycosylation of small GTP-binding proteins in the cytosol of target cells using activated nucleotide sugars as cosubstrates. Specific modification at a single threonine residue in the small GTPases renders these important key players of various signaling pathways inactive. This minireview intends to give an overview on structure-function analysis and mode of action of the large clostridial cytotoxins, as well as on the resulting functional consequences of glycosylation of target proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238250     DOI: 10.1016/j.bbagen.2004.03.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  36 in total

1.  Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.

Authors:  Rory N Pruitt; Nicole M Chumbler; Stacey A Rutherford; Melissa A Farrow; David B Friedman; Ben Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

Review 2.  A novel pathway for exotoxin delivery by an intracellular pathogen.

Authors:  Stefania Spanò; Jorge E Galán
Journal:  Curr Opin Microbiol       Date:  2008-02-20       Impact factor: 7.934

Review 3.  Sporulation and Germination in Clostridial Pathogens.

Authors:  Aimee Shen; Adrianne N Edwards; Mahfuzur R Sarker; Daniel Paredes-Sabja
Journal:  Microbiol Spectr       Date:  2019-11

4.  Fast neurotransmitter release regulated by the endocytic scaffold intersectin.

Authors:  Takeshi Sakaba; Natalia L Kononenko; Jelena Bacetic; Arndt Pechstein; Jan Schmoranzer; Lijun Yao; Holger Barth; Oleg Shupliakov; Oliver Kobler; Klaus Aktories; Volker Haucke
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-30       Impact factor: 11.205

5.  Dual role for RhoA in suppression and induction of cytokines in the human neutrophil.

Authors:  Michael B Fessler; Patrick G Arndt; Ingo Just; Jerry A Nick; Kenneth C Malcolm; G Scott Worthen
Journal:  Blood       Date:  2006-10-03       Impact factor: 22.113

6.  Characterization of Clostridium perfringens TpeL toxin gene carriage, production, cytotoxic contributions, and trypsin sensitivity.

Authors:  Jianming Chen; Bruce A McClane
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

7.  Holin-Dependent Secretion of the Large Clostridial Toxin TpeL by Clostridium perfringens.

Authors:  Angela Saadat; Stephen B Melville
Journal:  J Bacteriol       Date:  2021-03-23       Impact factor: 3.490

8.  EhRho1, a RhoA-like GTPase of Entamoeba histolytica, is modified by clostridial glucosylating cytotoxins.

Authors:  Shubhra Majumder; Gudula Schmidt; Anuradha Lohia; Klaus Aktories
Journal:  Appl Environ Microbiol       Date:  2006-10-20       Impact factor: 4.792

9.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

10.  Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis.

Authors:  Panagiotis Papatheodorou; Constantinos Zamboglou; Selda Genisyuerek; Gregor Guttenberg; Klaus Aktories
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.